The ABCD-GENE risk score confirmed a proposition of clinical and genotype components to identify patients at HRPR on clopidogrel in different populations with age, BMI, CKD, diabetes, and CYP2C19 LOF alleles (Angiolillo et al., 2020). This evidence concerns the gene CYP2C19 and diabetes mellitus.